ArticleBMC bioinformatics2025
FPGA-based accelerator for adaptive banded event alignment in nanopore sequencing data analysis.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAdaptive Banded Event Alignment (ABEA) stands as a critical algorithmic component in sequence polishing and DNA methylation detection, employing dynamic programming to align raw Nanopore signal with reference reads. Motivated by the observation that, compared to CPUs and GPUs, cutting-edge FPGAs demonstrate-in certain cases-superior performance at a reduced cost and energy consumption, this paper presents an efficient FPGA-based accelerator for ABEA, leveraging the inherent high parallelism and sequential access pattern within ABEA.
resultOur proposed FPGA-based ABEA accelerator significantly enhances ABEA performance compared to the original CPU-based implementation in Nanopolish as well as the state-of-art acceleration on GPU and FPGA platforms. Specifically, targeting Xilinx VU9P, our accelerator achieves an average throughput speedup of 10.05
conclusionOur work demonstrates that intensive genome analysis can benefit significantly from cutting-edge FPGAs, offering improvements in both performance and energy consumption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.